Stock Events

Stock Events

CytomX Therapeutics (CTMX) Q2 2026 Earnings

7MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.12

0.01

0.14

0.27

Details

Expected EPS

-0.121101

Actual EPS

-0.1

Surprise EPS

0.02

Surprise Percent

+17.42%

Description

CytomX Therapeutics (CTMX) has reported earnings of -0.1 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.